Who
Jill DeSimone
Director
Company insider
Files Form 4 as: Director, Praxis Precision Medicines; Director, Oncternal Therapeutics; Director, iTeos Therapeutics; Director, Kinnate Biopharma.
In numbers
- Trades disclosed
- 48
- Buys
- 1
- Sells
- 1
- Bought
- $25K
- Sold
- $7.2M
- Companies
- 4
- Companies where not an officer
- 4
- First trade
- 23 May 2022
- Last trade
- 24 Jun 2026
- Last filed
- 26 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 24 Jun 2026filed 26 Jun 2026 | PRAX Praxis Precision MedicinesBiotechnology | SEC FORM 4 Code M | $379K8,566 at $44.25 | filing |
| 24 Jun 2026filed 26 Jun 2026 | PRAX Praxis Precision MedicinesBiotechnology | SEC FORM 4 Sold | $890K2,854 at $311.91 | filing |
| 24 Jun 2026filed 26 Jun 2026 | PRAX Praxis Precision MedicinesBiotechnology | SEC FORM 4 Sold | $314K1,004 at $312.83 | filing |
| 24 Jun 2026filed 26 Jun 2026 | PRAX Praxis Precision MedicinesBiotechnology | SEC FORM 4 Sold | $158K504 at $313.66 | filing |
| 24 Jun 2026filed 26 Jun 2026 | PRAX Praxis Precision MedicinesBiotechnology | SEC FORM 4 Sold | $403K1,279 at $314.90 | filing |
| 24 Jun 2026filed 26 Jun 2026 | PRAX Praxis Precision MedicinesBiotechnology | SEC FORM 4 Sold | $264K837 at $315.71 | filing |
| 24 Jun 2026filed 26 Jun 2026 | PRAX Praxis Precision Medicinesoption or derivative · Biotechnology | SEC FORM 4 Code M | —8,566 at $0.00 | filing |
| 24 Jun 2026filed 26 Jun 2026 | PRAX Praxis Precision Medicinesoption or derivative · Biotechnology | SEC FORM 4 Code M | —3,034 at $0.00 | filing |
| 24 Jun 2026filed 26 Jun 2026 | PRAX Praxis Precision MedicinesBiotechnology | SEC FORM 4 Code M | $447K3,034 at $147.30 | filing |
| 24 Jun 2026filed 26 Jun 2026 | PRAX Praxis Precision MedicinesBiotechnology | SEC FORM 4 Sold | $3,01410 at $301.44 | filing |
| 24 Jun 2026filed 26 Jun 2026 | PRAX Praxis Precision Medicinesoption or derivative · Biotechnology | SEC FORM 4 Code M | —8,566 at $0.00 | filing |
| 24 Jun 2026filed 26 Jun 2026 | PRAX Praxis Precision Medicinesoption or derivative · Biotechnology | SEC FORM 4 Code M | —3,034 at $0.00 | filing |
| 24 Jun 2026filed 26 Jun 2026 | PRAX Praxis Precision MedicinesBiotechnology | SEC FORM 4 Sold | $36K120 at $303.13 | filing |
| 24 Jun 2026filed 26 Jun 2026 | PRAX Praxis Precision MedicinesBiotechnology | SEC FORM 4 Sold | $98K320 at $305.31 | filing |
| 24 Jun 2026filed 26 Jun 2026 | PRAX Praxis Precision MedicinesBiotechnology | SEC FORM 4 Sold | $210K683 at $306.77 | filing |
| 24 Jun 2026filed 26 Jun 2026 | PRAX Praxis Precision MedicinesBiotechnology | SEC FORM 4 Sold | $382K1,240 at $308.24 | filing |
| 24 Jun 2026filed 26 Jun 2026 | PRAX Praxis Precision MedicinesBiotechnology | SEC FORM 4 Sold | $309K999 at $309.38 | filing |
| 24 Jun 2026filed 26 Jun 2026 | PRAX Praxis Precision MedicinesBiotechnology | SEC FORM 4 Sold | $544K1,750 at $310.89 | filing |
| 24 Jun 2026filed 26 Jun 2026 | PRAX Praxis Precision MedicinesBiotechnology | SEC FORM 4 Code M | $379K8,566 at $44.25 | filing |
| 24 Jun 2026filed 26 Jun 2026 | PRAX Praxis Precision MedicinesBiotechnology | SEC FORM 4 Code M | $447K3,034 at $147.30 | filing |
News
Avalo Therapeutics (NASDAQ:AVTX) versus Praxis Precision Medicines (NASDAQ:PRAX) Financial AnalysisPRAX · tickerreport.com · 16 Oct 2026Analyzing Lisata Therapeutics (NASDAQ:LSTA) & Praxis Precision Medicines (NASDAQ:PRAX)PRAX · tickerreport.com · 11 Oct 2026
0 headlines in the last 90 days name Jill DeSimone; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.